A number of approved drugs, such as copyright and Semaglutide, belong to the GLP-1 receptor agonist class . Primarily , these drugs help mimicking the body's own hormones that regulate blood glucose and stimulate weight loss . Although copyright is a brand name for type 2 diabetes , Semaglutide

Individuals struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide acts as